Eisai Supports Earthquake Relief Efforts in Yunnan, China
November 27, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Eisai Supports Earthquake Relief Efforts in Yunnan, China - JCN Newswire
Share:
Eisai Supports Earthquake Relief Efforts in Yunnan, China

Tokyo, Aug 7, 2014 - (JCN Newswire) - Eisai expresses its heartfelt sympathies to all those affected by the recent earthquake which occurred in Ludian county of Zhaotong city, Yunnan province, China.

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it will provide emergency supplies worth approximately 10 million yen in order to support medical operations in the areas affected by the earthquake.

In order for these supplies to be deployed in relief efforts as soon as possible, the supplies will be rapidly delivered through Eisai's Chinese subsidiary Eisai China Inc. primarily to medical facilities in the region.

Eisai sincerely hopes that its activities will help the people affected by the earthquake and prays for the speedy recovery of the afflicted region.

About Eisai

Eisai Co., Ltd. (TSE: 4523; ADR: ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.

Contact:

Public Relations Department,
Eisai Co., Ltd.
+81-3-3817-5120

 


Aug 7, 2014
Source: Eisai

Eisai (TSE: 4523) (U.S: ESALY)

From the Japan Corporate News Network
http://www.japancorp.net
Topic: Disaster effects and responses
View more news from these Sectors: CSR, Biotech, Drugs & OTC


 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)